RXRX
USDRecursion Pharmaceuticals Inc. Class A Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$5.200
Kõrge
$5.320
Madal
$4.970
Maht
57.15M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
2.2B
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
39.05M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Recursion to Participate in Upcoming Investor Conferences
Salt Lake City, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following
Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
Salt Lake City, UT, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and
Buybacks take backseat as AI drives record US capex spending
Investors are increasingly favoring U.S. companies that channel capital toward AI innovation over those offering traditional shareholder payouts such as dividends and buybacks, even as the debate over soaring valuations and an AI bubble rages on.
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.